Nao Hondo

Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer

Shigeo Tokumaru, Tomonobu Koizumi, Yasushi Sekino et al. · Oncology · 2021 · 25 citations

MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells

Nao Hondo, Masato Kitazawa, Makoto Koyama et al. · Cancer Letters · 2023 · 20 citations · Full text

Medicine, Colorectal Cancer, Pathology +7

Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12DInhibitor, in Colorectal Cancer Treatment

Masahiro Kataoka, Masato Kitazawa, Satoshi Nakamura et al. · Anticancer Research · 2023 · 18 citations · Full text

Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG‑510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL‑XL

Masato Kitazawa, Yusuke Miyagawa, Makoto Koyama et al. · Molecular and Clinical Oncology · 2021 · 15 citations · Full text

Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells

Makoto Koyama, Masato Kitazawa, Satoshi Nakamura et al. · International Journal of Oncology · 2020 · 10 citations · Full text